Dosing

Research Update

Establishing a Dose-Response Relationship for Lurasidone in Acute Schizophrenia

Topics: Antipsychotics | Dose Response | Dosing | Lurasidone | Schizophrenia

REVIEW OF: Srisurapanont M et al, Sci Rep 2021:11(1):5571 STUDY TYPE: Network meta-analysis Lurasidone is FDA approved in schizophrenia, but we lack good evidence to guide its dosage. This study compared the efficacy, safety, and acceptability of lurasidone at different doses to establish a dose-response relationship for its therapeutic and adverse ef

Read More